There are two healthcare IPOs this week: BioForm Medical (BFRM), a medical aesthetics company that markets a dermal filler to treat facial wrinkles and volume loss; and The Ensign Group, Inc. (ENSG), a company that provides skilled nursing and rehabilitative care services through 60 skilled nursing facilities in 6 states.
All quotations are from the companies' most recent S-1 filings with links provided.
We are a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient’s appearance. Our core product is Radiesse, an injectable dermal filler designed to provide long-lasting, cost-effective and safe aesthetic improvement for patients. Our clinical studies have demonstrated that Radiesse provides meaningful initial aesthetic correction and approximately 12 months’ duration of aesthetic improvement in many patients, resulting in high patient satisfaction. Physicians have used Radiesse for more than five years, and, we have shipped over 500,000 syringes worldwide.
Offering: 10.0 million shares at $9.00 - $11.00 per share. Net proceeds of approximately $90.8 million will be used for sales and marketing activities, R&D, to acquire a license from Artes Medical and for general corporate purposes.
Lead Underwriters: J.P. Morgan, Piper Jaffray
Net sales increased 109% from $22.7 million in fiscal 2006 to $47.4 million in fiscal 2007... Cost of sales increased from $4.3 million in fiscal 2006 to $8.8 million in fiscal 2007, primarily due to the increase in our sales. Our gross profit margin increased slightly from 81% to 82%... Sales and marketing expenses increased from $20.7 million in fiscal 2006 to $38.2 million in fiscal 2007... The loss per share declined in fiscal 2007 from fiscal 2006 due to an increase in the number of shares outstanding as a result of the exercise of stock options by employees, partially offset by an increase in net loss.
- Company website
- Online road show
- San Jose Business Journal: 'BioForm to pay $5.5M in royalties to Artes'
- AP: 'BioForm Medical Sets Terms of IPO'
We are a provider of skilled nursing and rehabilitative care services through the operation of facilities located in California, Arizona, Texas, Washington, Utah and Idaho. As of September 30, 2007, we owned or leased 61 facilities. All of our facilities are skilled nursing facilities, except for four facilities that offer both skilled nursing and assisted living arrangements in a campus setting, and three stand-alone assisted living facilities. At our facilities, each of which strives to be the facility of choice in the community it serves, we provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients. Our facilities have a collective capacity of over 7,400 skilled nursing, assisted living and independent living beds. As of September 30, 2007, we owned 23 of our facilities and operated an additional 38 facilities under long-term lease arrangements with options to purchase 12 of those 38 facilities. We also have entered into agreements to purchase four of the 38 facilities that we operate under long-term lease arrangements, which are pending subject to certain closing conditions. For the year ended December 31, 2006 and the six months ended June 30, 2007, our skilled nursing services, including our integrated rehabilitative therapy services, generated approximately 97% of our revenue.
Offering: 4.0 million shares at $18.00 - $20.00 per share. Net proceeds of approximately $68,020,000 will be used to acquire additional facilities, for expansion, improvements and upgrades to the company's existing facilities and to pay down debt.
Lead Underwriters: D.A. Davidson, Stifel Nicolaus
Revenue increased $29.5 million, or 17.5%, to $198.2 million for the six months ended June 30, 2007 compared to $168.7 million for the six months ended June 30, 2006... Cost of services increased $27.6 million, or 20.8%, to $161.0 million for the six months ended June 30, 2007 compared to $133.4 million for the six months ended June 30, 2006... General and administrative expense increased $1.0 million, or 16.0%, to $7.6 million for the six months ended June 30, 2007 compared to $6.6 million for the six months ended June 30, 2006.
- Company website
- Online road show
- Orange County Business Journal: 'Nursing Home Operator Ensign Courts Wall St.; Private Equity Fallback?'
- Orange County Business Journal:'Ensign Group Notches Down Pending Public Offering'